Basic Hepatology最新文献

筛选
英文 中文
IDDF2022-ABS-0106 Iron status and non-alcoholic fatty liver disease: a mendelian randomization study 铁状态与非酒精性脂肪性肝病:一项孟德尔随机研究
Basic Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.21
K. Sun, Jie Zhao, Edmund Anthony Severn Nelson, L. Hui
{"title":"IDDF2022-ABS-0106 Iron status and non-alcoholic fatty liver disease: a mendelian randomization study","authors":"K. Sun, Jie Zhao, Edmund Anthony Severn Nelson, L. Hui","doi":"10.1136/gutjnl-2022-iddf.21","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.21","url":null,"abstract":"","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114784776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0161 Tertiary lymphoid structures promote hepatocellular carcinoma immunotherapy 三级淋巴样结构促进肝癌免疫治疗
Basic Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.22
Jinyang Li, Xinxiang Yang, Jiye Zhu, K. Man
{"title":"IDDF2022-ABS-0161 Tertiary lymphoid structures promote hepatocellular carcinoma immunotherapy","authors":"Jinyang Li, Xinxiang Yang, Jiye Zhu, K. Man","doi":"10.1136/gutjnl-2022-iddf.22","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.22","url":null,"abstract":"","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128352063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0261 Fatty acid desaturase 1 mediating metabolic reprogramming of polyunsaturated fatty acids promotes HCC progression by impairing CD8+ T cell anti-tumor immunity 脂肪酸去饱和酶1介导多不饱和脂肪酸代谢重编程,通过损害CD8+ T细胞抗肿瘤免疫促进HCC进展
Basic Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.29
Tao Ding, L. Pang, Jiang Liu, K. Ng, O. W. Yeung, Hui Liu, Zhe Wang, Shinuan Zeng, Jinyang Li, K. Man
{"title":"IDDF2022-ABS-0261 Fatty acid desaturase 1 mediating metabolic reprogramming of polyunsaturated fatty acids promotes HCC progression by impairing CD8+ T cell anti-tumor immunity","authors":"Tao Ding, L. Pang, Jiang Liu, K. Ng, O. W. Yeung, Hui Liu, Zhe Wang, Shinuan Zeng, Jinyang Li, K. Man","doi":"10.1136/gutjnl-2022-iddf.29","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.29","url":null,"abstract":"","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125330182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0247 YTHDF1-EZH2-il-6 axis fuels anti-PD-1 resistance in nash-HCC YTHDF1-EZH2-il-6轴促进nash-HCC的抗pd -1耐药
Basic Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.28
Lina Wang, Xiang Huang, Lefan Zhu, Jihui Huo, Cong Liang, Lixia Xu, Xiaoxing Li
{"title":"IDDF2022-ABS-0247 YTHDF1-EZH2-il-6 axis fuels anti-PD-1 resistance in nash-HCC","authors":"Lina Wang, Xiang Huang, Lefan Zhu, Jihui Huo, Cong Liang, Lixia Xu, Xiaoxing Li","doi":"10.1136/gutjnl-2022-iddf.28","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.28","url":null,"abstract":"","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"63 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129949838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0047 Prevalence and associated risk factors of hepatitis B infection among healthcare workers at a tertiary public hospital in the philippines 菲律宾一家三级公立医院医护人员乙型肝炎感染的患病率及相关危险因素
Basic Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.18
John Mark Torres
{"title":"IDDF2022-ABS-0047 Prevalence and associated risk factors of hepatitis B infection among healthcare workers at a tertiary public hospital in the philippines","authors":"John Mark Torres","doi":"10.1136/gutjnl-2022-iddf.18","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.18","url":null,"abstract":"","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130641943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0194 Patient-derived organoids predict chemotherapy response in biliary tract cancer IDDF2022-ABS-0194患者源性类器官预测胆道癌化疗反应
Basic Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.25
Xiaoxue Ren, Yifan Wu, Mingle Huang, Yubin Xie, M. Kuang, Xiaoxing Li, Lixia Xu
{"title":"IDDF2022-ABS-0194 Patient-derived organoids predict chemotherapy response in biliary tract cancer","authors":"Xiaoxue Ren, Yifan Wu, Mingle Huang, Yubin Xie, M. Kuang, Xiaoxing Li, Lixia Xu","doi":"10.1136/gutjnl-2022-iddf.25","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.25","url":null,"abstract":"","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126845929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0267 HLA-E/NKG2A hampers tumor surveillance of natural killer cells induced by TLR4-mediated hepatic senescence IDDF2022-ABS-0267 HLA-E/NKG2A阻碍tlr4介导的肝衰老诱导的自然杀伤细胞的肿瘤监测
Basic Hepatology Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.30
X. Yang, K. Man, K. Ng
{"title":"IDDF2022-ABS-0267 HLA-E/NKG2A hampers tumor surveillance of natural killer cells induced by TLR4-mediated hepatic senescence","authors":"X. Yang, K. Man, K. Ng","doi":"10.1136/gutjnl-2022-iddf.30","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.30","url":null,"abstract":"","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122163342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2021-ABS-0185 Overcome primary resistance to immune checkpoint blockade in hepatocellular carcinoma IDDF2021-ABS-0185克服肝细胞癌免疫检查点阻断的原发性耐药
Basic Hepatology Pub Date : 2021-09-01 DOI: 10.1136/gutjnl-2021-iddf.9
Xiaoyu Liu, Jingying Zhou, Man Liu, Ying Wang, Mengying Hu, Rihe Liu, Leaf Huang, Hanzhuang Liu, Alfred Sze Lok Cheng
{"title":"IDDF2021-ABS-0185 Overcome primary resistance to immune checkpoint blockade in hepatocellular carcinoma","authors":"Xiaoyu Liu, Jingying Zhou, Man Liu, Ying Wang, Mengying Hu, Rihe Liu, Leaf Huang, Hanzhuang Liu, Alfred Sze Lok Cheng","doi":"10.1136/gutjnl-2021-iddf.9","DOIUrl":"https://doi.org/10.1136/gutjnl-2021-iddf.9","url":null,"abstract":"Background Although immune checkpoint blockade (ICB) such as anti-programmed cell death 1 or its ligand (anti-PD-1/PD-L1) has revolutionized the treatment paradigm for cancer patients, most hepatocellular carcinoma (HCC) patients did not show benefits in the clinical scenario. The aim of this study is to investigate the underlying mechanisms of immunotherapy resistance in HCC and explore therapeutic approaches for enhancing HCC immunotherapy. Methods Fibrosis-associated HCC mouse model was established by chemical induction and tumor inoculation. Non-alcoholic fatty liver disease (NAFLD)-associated HCC was established by high-fat high carbohydrate diet and tumor implantation. Integrated analysis of single-cell RNA sequencing and bulk RNA sequencing were applied to identify monocytic myeloid-derived suppressor cells (M-MDSC) signature genes. Immune profiles were determined by flow cytometry. Results We found M-MDSC was specifically enriched in non-responders and a protein phosphatase was identified as a novel signature gene in M-MDSC. Inhibition of this protein phosphatase suppressed M-MDSC expansion and reduced reactive oxygen species generation, which holds promise in ameliorating the immunosuppressive microenvironment for tumor eradication. To further improve HCC therapy in ICB manner, we found an elegant nanoparticle-parceled PD-L1 trap which was superior to the conventional antibody-mediated ICB therapy. This PD-L1 trap was more up taken by the fibrotic liver environment compared to the normal liver indicating it would be suitable for majority of HCC patients. Ultimately, the PD-L1 trap triggered robust anti-tumor response in both fibrotic HCC and NAFLD-associated HCC. Mechanistically, PD-L1 trap exerted potent immune-editing function by diminishing immunosuppressive cells and boosting CD8+ T cells infiltration to the tumor. Those tumor-infiltrating CD8+ T cells were more cytotoxic with augmented cytokines production. More importantly, improved survival was observed in PD-L1 trap-treated HCC. Conclusions We uncovered a novel target for immunosuppressive myeloid cells which was closely associated with immunotherapy resistance in HCC. Moreover, a novel ICB approach showed translational potential for treating HCC with the enhanced therapeutic effect but reduced toxicity. We anticipate providing more efficacious options for HCC patients with long-term benefits. Acknowledgements: This study is supported by HMRF (16170451, 07180556) and Li Ka Shing Foundation.","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121091963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2021-ABS-0177 RNF135 promoter methylation is associated with immune infiltration and prognosis in hepatocellular carcinoma RNF135启动子甲基化与肝细胞癌的免疫浸润和预后相关
Basic Hepatology Pub Date : 2021-09-01 DOI: 10.1136/gutjnl-2021-iddf.8
Gui-jun Zhao, Xiong Liang, Yu-Ru Bai, Hao Li, Guang Yong, Yusha Liu, Yukun Liang, Xiao Wang
{"title":"IDDF2021-ABS-0177 RNF135 promoter methylation is associated with immune infiltration and prognosis in hepatocellular carcinoma","authors":"Gui-jun Zhao, Xiong Liang, Yu-Ru Bai, Hao Li, Guang Yong, Yusha Liu, Yukun Liang, Xiao Wang","doi":"10.1136/gutjnl-2021-iddf.8","DOIUrl":"https://doi.org/10.1136/gutjnl-2021-iddf.8","url":null,"abstract":"Background RING finger protein 135 (RNF135) has an important role in the occurrence of many cancers, however, the regulation and function of RNF135 in hepatocellular carcinoma (HCC) remains unknown. Methods The promoter methylation status and mRNA expression of RNF135 were evaluated by methylation-specific PCR and real-time PCR in HCC cell lines and tissues, and further analyzed from The Cancer Genome Atlas database. Transwell migration, wound healing assay, cell viability, and colony formation assay were performed to investigate the function of RNF135. GSEA analysis, TIMER database and ESTIMATE algorithm were used to decipher the associated pathway and immune infiltration. The survival analysis was applied to assess the prognostic value of RNF135. Results RNF135 expression was downregulated in 5 of 8 HCC cell lines and HCC tissues, and was negatively correlated with its promoter hypermethylation. Demethylating regent decitabine restored RNF135 expression on the cellular level. Knockdown of RNF135 expression enhanced the migration of HCC cells, while RNF135 overexpression repressed cell migration. Bioinformatics analysis revealed a positive relationship between RNF135 expression and six immune cell infiltrates (B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and dendritic cells). Survival analysis disclosed that RNF135 hypermethylation is independently associated with poor clinical outcomes in HCC. Conclusions Decreased RNF135 expression driven by promoter hypermethylation is frequently occurred in HCC and associated with prognosis of HCC. RNF135 functions as a tumor suppressor and involves in tumor immune microenvironment in HCC.","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"177 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131720887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2021-ABS-0073 Characteristics of biliary microbes in patients with recurrent choledocholithiasis IDDF2021-ABS-0073复发性胆总管结石患者的胆道微生物特征
Basic Hepatology Pub Date : 2021-09-01 DOI: 10.1136/gutjnl-2021-iddf.16
Wen-hui Tan, Ruiyan Chen, Jianchuan Wu, Fang Wang, Biao Liang
{"title":"IDDF2021-ABS-0073 Characteristics of biliary microbes in patients with recurrent choledocholithiasis","authors":"Wen-hui Tan, Ruiyan Chen, Jianchuan Wu, Fang Wang, Biao Liang","doi":"10.1136/gutjnl-2021-iddf.16","DOIUrl":"https://doi.org/10.1136/gutjnl-2021-iddf.16","url":null,"abstract":"Background To observe the characteristics of biliary tract microorganisms in patients with recurrent choledocholithiasis, and to analyze the influence of biliary tract microorganisms on the recurrence of choledocholithiasis. Methods The of tract","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132570424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信